Who
Thomas John Dietz
Director
Company insider
Files Form 4 as: Director, Cypherpunk Technologies; Director, Paratek Pharmaceuticals; Director, Eiger BioPharmaceuticals.
In numbers
- Trades disclosed
- 82
- Buys
- 8
- Sells
- 5
- Bought
- $370K
- Sold
- $193K
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 10 Apr 2013
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Sold | $34K20,000 at $1.72 | filing |
| 26 Aug 2026filed 27 Aug 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Sold | $34K20,000 at $1.72 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —104,500 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —104,500 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —104,500 at $0.00 | filing |
| 13 Mar 2026filed 17 Mar 2026 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —104,500 | filing |
| 26 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —83,000 at $0.00 | filing |
| 26 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code M | —83,000 | filing |
| 26 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk TechnologiesBiotechnology | SEC FORM 4 Code F | $42K35,000 at $1.20 | filing |
| 23 Dec 2025filed 30 Dec 2025 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,500 at $0.00 | filing |
| 11 Nov 2025filed 13 Nov 2025 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,000 at $0.00 | filing |
| 2 Oct 2024filed 4 Oct 2024 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 Jan 2024filed 31 Jan 2024 | CYPH Cypherpunk Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —7,000 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —7,000 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —5,000 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —5,000 | filing |
| 21 Sep 2023filed 21 Sep 2023 | Paratek Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —6,000 | filing |
News
No headline names them, or the companies they trade most, lately.